Skip to main content
. Author manuscript; available in PMC: 2020 May 26.
Published in final edited form as: Surgery. 2015 Oct 9;159(1):250–257. doi: 10.1016/j.surg.2015.08.038

Figure 4: Clinical Analysis.

Figure 4:

Various clinical parameters (patient gender, age, tumor size ENSAT stage, metastasis, hormone secretory status, and disease-free survival) were assessed for association with SLC12A7 expression patterns and amplifications. A Higher expression levels was observed in non-functional tumors, but the difference did not reach statistical significance (p=0.08). B & C SLC12A7 amplifications were higher in non-functional tumors (*, p<0.05, 2-tailed t test), as well as male patients (†, p<0.05, 2-tailed t test). Horizontal bar, mean; Error bars, SEM.